Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 1 |
2014 | 2 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.
N Engl J Med. 2017.
PMID: 28002688
Free article.
Clinical Trial.
Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements.
Oreja-Guevara C, Tintoré M, Meca V, Prieto JM, Meca J, Mendibe M, Rodríguez-Antigüedad A.
Oreja-Guevara C, et al. Among authors: meca v.
Cureus. 2023 Aug 24;15(8):e44056. doi: 10.7759/cureus.44056. eCollection 2023 Aug.
Cureus. 2023.
PMID: 37746391
Free PMC article.
Item in Clipboard
Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.
Nann D, Rau A, Mahmutovic L, Steinhilber J, Meca V, Federmann B, Vogel W, Bonzheim I, Quintanilla-Martinez L, Fend F.
Nann D, et al. Among authors: meca v.
Virchows Arch. 2023 Dec;483(6):835-845. doi: 10.1007/s00428-023-03627-1. Epub 2023 Aug 23.
Virchows Arch. 2023.
PMID: 37610626
Free PMC article.
Item in Clipboard
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
de la Hera B, Urcelay E, Brassat D, Chan A, Vidal-Jordana A, Salmen A, Villar LM, Alvarez-Cermeño JC, Izquierdo G, Fernández O, Oliver B, Saiz A, Ara JR, Vigo AG, Arroyo R, Meca V, Malhotra S, Fissolo N, Horga A, Montalban X, Comabella M.
de la Hera B, et al. Among authors: meca v.
Neurol Neuroimmunol Neuroinflamm. 2014 Dec 11;1(4):e47. doi: 10.1212/NXI.0000000000000047. eCollection 2014 Dec.
Neurol Neuroimmunol Neuroinflamm. 2014.
PMID: 25520955
Free PMC article.
Item in Clipboard
Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
Hernández MA, Mora S; grupo de trabajo del Estudio SLIMS.
Hernández MA, et al.
Neurologia. 2013 Jul-Aug;28(6):340-7. doi: 10.1016/j.nrl.2012.06.003. Epub 2012 Oct 12.
Neurologia. 2013.
PMID: 23067780
Free article.
English, Spanish.
Item in Clipboard
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Saiz A, Mora S, Blanco J; en representación de los investigadores del estudio COMPLIANCE.
Saiz A, et al.
Neurologia. 2015 May;30(4):214-22. doi: 10.1016/j.nrl.2013.12.008. Epub 2014 Jan 28.
Neurologia. 2015.
PMID: 24484756
Free article.
English, Spanish.
Item in Clipboard
Cite
Cite